{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:00:48Z","timestamp":1787590848064,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.canlet.2022.215862","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T17:25:15Z","timestamp":1659979515000},"page":"215862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16\/IGF2BP3 axis in gallbladder cancer"],"prefix":"10.1016","volume":"547","author":[{"given":"Shilei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangsong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2022.215862_bib1","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200726","article-title":"Gallbladder cancer revisited: the evolving role of a radiologist","volume":"94","author":"Ramachandran","year":"2021","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canlet.2022.215862_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41392-020-00324-2","article-title":"Overview of current targeted therapy in gallbladder cancer","volume":"5","author":"Song","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2022.215862_bib3","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1158\/2159-8290.CD-17-0245","article-title":"New horizons for precision medicine in biliary tract cancers","volume":"7","author":"Valle","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2022.215862_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jhep.2020.03.007","article-title":"Molecular targeted therapies: ready for \"prime time\" in biliary tract cancer","volume":"73","author":"Lamarca","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2022.215862_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.canlet.2021.09.004","article-title":"Worldwide distribution, associated factors, and trends of gallbladder cancer: a global country-level analysis","volume":"521","author":"Huang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2022.215862_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215257","article-title":"Current insights in genetic alterations and their possible therapeutic implications","volume":"13","author":"Kuipers","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2022.215862_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2022.215862_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canlet.2017.12.029","article-title":"Statistical analysis of non-coding RNA data","volume":"417","author":"He","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2022.215862_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.semcancer.2021.03.029","article-title":"Dysregulations of long non-coding RNAs - the emerging \"lnc\" in environmental carcinogenesis","volume":"76","author":"Wang","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canlet.2022.215862_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.canlet.2020.11.048","article-title":"LncRNAs in cancer: regulatory and therapeutic implications","volume":"501","author":"Nandwani","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2022.215862_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12943-019-1097-9","article-title":"LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p\/SET\/AKT axis","volume":"18","author":"Hu","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215862_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2022.215862_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2020.08.004","article-title":"A-to-I RNA editing as a tuner of noncoding RNAs in cancer","volume":"494","author":"Liao","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2022.215862_bib14","doi-asserted-by":"crossref","first-page":"498","DOI":"10.7150\/ijbs.55636","article-title":"DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163\/TOP2A and activating Wnt\/\u03b2-catenin pathway","volume":"17","author":"Liu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2022.215862_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canlet.2021.04.002","article-title":"LncRNA-miRNA axes in breast cancer: novel points of interaction for strategic attack","volume":"509","author":"Venkatesh","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2022.215862_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12943-020-01201-w","article-title":"Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2'-O-methylation via NOP58 recruitment in colorectal cancer","volume":"19","author":"Wu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215862_bib17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12943-019-1079-y","article-title":"Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m(6)A reader YTHDF3","volume":"18","author":"Ni","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215862_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12943-019-1104-1","article-title":"TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2","volume":"19","author":"Shuai","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215862_bib19","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1158\/0008-5472.CAN-20-3747","article-title":"MYC-activated LncRNA MNX1-AS1 promotes the progression of colorectal cancer by stabilizing YB1","volume":"81","author":"Wu","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2022.215862_bib20","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41419-020-03029-0","article-title":"LncRNA MNX1-AS1 promotes progression of intrahepatic cholangiocarcinoma through the MNX1\/Hippo axis","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2022.215862_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112801","article-title":"LncRNA MNX1-AS1: a novel oncogenic propellant in cancers","volume":"149","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2022.215862_bib22","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.15252\/embr.201744147","article-title":"LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis","volume":"18","author":"Wu","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.canlet.2022.215862_bib23","first-page":"71","article-title":"Role of long noncoding RNA in neuroblastoma","volume":"30","author":"Ye","year":"2020","journal-title":"Discov. Med."},{"key":"10.1016\/j.canlet.2022.215862_bib24","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1038\/s41418-018-0242-0","article-title":"A DHX9-lncRNA-MDM2 interaction regulates cell invasion and angiogenesis of cervical cancer","volume":"26","author":"Ding","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2022.215862_bib25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41418-019-0381-y","article-title":"The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1\u03b1","volume":"27","author":"Wang","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2022.215862_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/apm.13186","article-title":"High YAP and TEAD4 immunolabelings are associated with poor prognosis in patients with gallbladder cancer","volume":"129","author":"Kim","year":"2021","journal-title":"Apmis"},{"key":"10.1016\/j.canlet.2022.215862_bib27","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.7150\/thno.47830","article-title":"LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2022.215862_bib28","first-page":"1176","article-title":"A novel positive feedback regulation between long noncoding RNA UICC and IL-6\/STAT3 signaling promotes cervical cancer progression","volume":"8","author":"Su","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.canlet.2022.215862_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3389\/fcell.2020.00717","article-title":"USP7 is a master regulator of genome stability","volume":"8","author":"Valles","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2022.215862_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.3192","article-title":"The landscape of long noncoding RNAs in the human transcriptome","volume":"47","author":"Iyer","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2022.215862_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/CBM-170979","article-title":"The emerging roles of long non-coding RNA in gallbladder cancer tumorigenesis","volume":"22","author":"Chen","year":"2018","journal-title":"Cancer Biomarkers"},{"key":"10.1016\/j.canlet.2022.215862_bib32","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.7150\/jca.46351","article-title":"DGCR5 promotes gallbladder cancer by sponging MiR-3619-5p via MEK\/ERK1\/2 and JNK\/p38 MAPK pathways","volume":"11","author":"Liu","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2022.215862_bib33","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm.3981","article-title":"The emerging role of lncRNAs in cancer","volume":"21","author":"Huarte","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2022.215862_bib34","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","article-title":"Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches","volume":"96","author":"Beermann","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.canlet.2022.215862_bib35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jmg.39.8.575","article-title":"Characterisation of the growth regulating gene IMP3, a candidate for Silver-Russell syndrome","volume":"39","author":"Monk","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.canlet.2022.215862_bib36","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1038\/sj.onc.1201110","article-title":"Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein","volume":"14","author":"M\u00fceller-Pillasch","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2022.215862_bib37","doi-asserted-by":"crossref","first-page":"18466","DOI":"10.1002\/jcp.28483","article-title":"Increased IGF2BP3 expression promotes the aggressive phenotypes of colorectal cancer cells in vitro and vivo","volume":"234","author":"Xu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2022.215862_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12943-017-0647-2","article-title":"IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis","volume":"16","author":"Zhou","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2022.215862_bib39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.canlet.2022.215862_bib40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biocel.2018.06.001","article-title":"Ubiquitination: friend and foe in cancer","volume":"101","author":"Mansour","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.canlet.2022.215862_bib41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10555-016-9640-2","article-title":"The role of deubiquitinases in breast cancer","volume":"35","author":"Xiao","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2022.215862_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","article-title":"Mechanisms of deubiquitinase specificity and regulation","volume":"86","author":"Mevissen","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.canlet.2022.215862_bib43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12929-019-0522-0","article-title":"The role of ubiquitin-specific peptidases in cancer progression","volume":"26","author":"Young","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.canlet.2022.215862_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.canlet.2021.05.004","article-title":"Ubiquitin-specific peptidase 22 in cancer","volume":"514","author":"Feng","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2022.215862_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040778","article-title":"Hippo-YAP1 is a prognosis marker and potentially targetable pathway in advanced gallbladder cancer","volume":"12","author":"Garc\u00eda","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2022.215862_bib46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.canlet.2020.08.012","article-title":"Interaction of non-coding RNAs and Hippo signaling: implications for tumorigenesis","volume":"493","author":"Liu","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2022.215862_bib47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrc3876","article-title":"The emerging roles of YAP and TAZ in cancer","volume":"15","author":"Moroishi","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2022.215862_bib48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2021.03.006","article-title":"Hippo pathway: regulation, deregulation and potential therapeutic targets in cancer","volume":"507","author":"Mohajan","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2022.215862_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrd4161","article-title":"The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment","volume":"13","author":"Johnson","year":"2014","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522003469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383522003469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:05:23Z","timestamp":1759593923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383522003469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":49,"alternative-id":["S0304383522003469"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215862","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16\/IGF2BP3 axis in gallbladder cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2022.215862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"215862"}}